Glenmark partners with Particle Sciences in Abraxane generic deal

27-09-2016

Glenmark partners with Particle Sciences in Abraxane generic deal

Artco / Shutterstock.com

India-based pharmaceutical company Glenmark has signed a wide-ranging drug agreement with Particle Sciences, a provider of drug development services.


Glenmark, Particle Sciences, licensing, ANDA, Abraxane, generics

More on this story

Celgene reaches settlement with Actavis
31-01-2018

LSIPR